Resultados de la búsqueda 231-240 of 14672 for Severe hypertriglyceridaemia

  1. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Cell, Serum, and Buccal Bank for Patients with Chronic Myeloid Disorders and Acute Leukemia. Rochester, Minn. This study is being done to store blood, buccal ...

  3. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

    The primary purpose/objective of this study is to determine whether myectomy as a management option for severe hypertrophic cardiomyopathy (HCM) reduces the ...

  4. Mayo Clinic Physician Update - October 2025

    Page 1.

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This proposal will begin intense lymphedema screening and identify baseline characteristics potentially predisposing someone to lymphedema, and identify ...

  6. Cáncer de próstata - Médicos y departamentos - Mayo Clinic

    707 4.293 8 8.9 ">Diag.707 43586 12.293 4.293 13.707 5.707 8 11.414z">&quodb0EAmp.707 4.293 8 8.586 12.293 4.293 lass="aem-GridColumn aem7"-iiiogo,umn aem- ...

  7. Medicina cardiovascular - Ensayos clínicos

    The aim of this study is to evaluate the relation of the acute pacing threshold (volts at 'x' pulse width) to the chronic pacing threshold of a pacemaker/ICD ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    ... Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary efficacy of mosunetuzumab ...

  10. Neurología - Ensayos clínicos - Mayo Clinic

    A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.